3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Glioblastoma
4
Small Cell Lung Carcinoma
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Gliosarcoma
3
Fallopian Tube Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Astrocytoma
3
Rectal Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Glioma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Interventions
Paclitaxel
9
Carboplatin
6
Cisplatin
5
Hyperthermic Intraperitoneal Chemotherapy
4
Oxaliplatin
3
Fluorouracil
3
Cytoreduction Surgical Procedures
3
Bevacizumab
3
nintedanib
2
Mitomycin
2
Leucovorin
2
Laparoscopy
2
Gemcitabine
2
Folfox protocol
2
Docetaxel
2
vandetanib
1
talimogene laherparepvec
1
strattice
1
sodium thiosulfate
1
poly(I).poly(c12,U)
1
pembrolizumab
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
farletuzumab
1
enzastaurin
1
catumaxomab
1
birinapant
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Peritoneal Neoplasms
×
veliparib
×
Clear all
No trials found.